Rock Springs Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-900,000
| Closed | -$4.61M | – | 141 |
|
|
2019
Q3 | $4.61M | Hold |
900,000
| – | – | 0.18% | 107 |
|
|
2019
Q2 | $6.44M | Buy |
900,000
+185,000
| +26% | +$1.32M | 0.23% | 91 |
|
|
2019
Q1 | $9.5M | Buy |
715,000
+101,396
| +17% | +$1.35M | 0.37% | 83 |
|
|
2018
Q4 | $4.83M | Hold |
613,604
| – | – | 0.23% | 97 |
|
|
2018
Q3 | $6.8M | Buy |
613,604
+33,604
| +6% | +$372K | 0.25% | 101 |
|
|
2018
Q2 | $7.78M | Buy |
580,000
+90,000
| +18% | +$1.21M | 0.3% | 97 |
|
|
2018
Q1 | $6.37M | Buy |
490,000
+40,000
| +9% | +$520K | 0.27% | 102 |
|
|
2017
Q4 | $4.14M | Hold |
450,000
| – | – | 0.19% | 113 |
|
|
2017
Q3 | $3.63M | Buy |
+450,000
| New | +$3.63M | 0.17% | 113 |
|
|
2015
Q1 | – | Sell |
-100,000
| Closed | -$983K | – | 109 |
|
|
2014
Q4 | $983K | Sell |
100,000
-200,000
| -67% | -$1.97M | 0.12% | 92 |
|
|
2014
Q3 | $2.05M | Buy |
+300,000
| New | +$2.05M | 0.32% | 75 |
|